Safecor Health Expands Horizons with Acquisition of Viatris' Unit-Dose Business
Deal News | Nov 18, 2024 | Vesey Street Capital Partners
Safecor Health, a leader in pharmaceutical unit-dose repackaging, has announced its acquisition of Viatris Inc.'s U.S. unit-dose packaging business, previously known as Unit Dose Laboratories. The acquisition will allow Safecor to expand its product offerings and strengthen its market presence. Safecor CEO Mark Saxon expressed high hopes for integrating UDL's brand recognition and capabilities, which will enhance their packaging and supply chain solutions for healthcare systems, manufacturers, and wholesalers. Viatris’ UDL unit has been recognized as a national leader in offering over 400 generic medicines and has state-of-the-art facilities in Rockford, Illinois. The transaction is expected to be completed by mid-2025, and it represents a strategic move to deepen Safecor's relationships within the healthcare supply chain market. Vesey Street Capital Partners, a private equity firm known for its investments in healthcare services, owns Safecor Health.
Sectors
- Healthcare Services
- Pharmaceutical Manufacturing
- Private Equity
Geography
- United States – The business operations and acquisition are centered in the United States, specifically with facilities in Rockford, Illinois.
Industry
- Healthcare Services – Both Safecor Health and the UDL segment of Viatris provide critical healthcare services, specifically focusing on pharmaceutical packaging and supply chain solutions.
- Pharmaceutical Manufacturing – The acquisition involves the unit-dose packaging of pharmaceutical products, which is an integral part of the pharmaceutical manufacturing industry.
- Private Equity – Vesey Street Capital Partners, a private equity firm, is involved in the transaction as the owner of Safecor Health.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Safecor Health | Acquirer | Company | A market leader in pharmaceutical unit-dose repackaging and supply chain solutions. |
| Viatris Inc. | Vendor | Company | A global pharmaceutical company selling its U.S. unit-dose packaging business. |
| Vesey Street Capital Partners | Owner of Safecor Health | Company | A private equity firm specializing in buyouts of healthcare service businesses. |
| UDL (Unit Dose Laboratories) | Target Business | Company | The unit-dose packaging business being acquired from Viatris. |
| Mark Saxon | CEO of Safecor Health | Person | Leading Safecor Health's strategic acquisition. |
| Kriss Spors | Head of Site Operations transitioning to Safecor | Person | Overseeing site operations for the acquired UDL business. |